Described herein are methods and compositions for inhibiting, treating andreversing intervertebral disc disorders using transcription factor inhibitors.In certain embodiments, the transcription factor inhibitor targets thetranscription factor NF-.kappa.B. Also described are methods and compositionswhere intervertebral disc disorder is reversed using a decoy oligodeoxy-nucleotide that blocks NF-.kappa.B.